Expanding our culture of compliance
Our expanding network of experienced compliance professionals in the Office of Compliance manage and execute Cencora’s Compliance Program throughout the global enterprise by providing team members with proactive support, guidance, and tailored controls, enabling the business to identify and mitigate compliance risk. Leveraging this guidance, all Cencora team members are held accountable for the success of our Compliance Program. The Office of Compliance also partners closely with experts in the Privacy Department to manage and execute Cencora’s Privacy Program throughout the global enterprise. This collaboration ensures that all privacy-related policies and procedures are consistently implemented and adhered to, safeguarding personal and sensitive information in compliance with international regulations and standards.
We believe in transparency and operating with the highest ethical standards. We encourage our team members to speak up if they have a question regarding compliance matters or a concern about a potential violation of our Code of Ethics and Business Conduct or other Cencora policies. Team members may contact our SpeakUp Program online or by phone, with an option to report anonymously, where permitted by local country law. Cencora is committed to our whistleblower policy, meaning that team members will never suffer an adverse impact to their employment for raising a compliance question or concern.
Reinforcing a culture of compliance through the pursuit of our purpose is foundational to our strategy. As our footprint expands, we continue to globalize policies and centralize procedures and controls enabling team members in all geographies in which Cencora does business to meet their business objectives and responsibilities in a compliant and ethical manner. This past year, the team focused on enhancing and centralizing our policies and procedures designed to address trade controls, including compliance with trade sanctions issued by the United States, United Kingdom, and European Union, as well as import and export controls. Our trade controls program includes screening for certain high-risk third parties with which the company does business. The compliance team also further developed our compliance data monitoring program, including identifying and prioritizing risk areas; identifying available data/information for monitoring; generating analytics and insights; implementing processes for review and action; measuring effectiveness; and incorporating insights into compliance risk assessment activities.
Keeping team members actively engaged
As a key partner that enables access to therapies people and animals need, we are acutely aware that every interaction we have with stakeholders such as pharmaceutical companies, prescribers, pharmacists, and other health care providers, as well as payors and patients, must be grounded in ethics and transparency. Our Compliance Program provides guidance for these interactions and is designed to prevent improper influence of healthcare decision-making.
This year, we further aligned the timing of our annual Compliance training launch to coincide with the beginning of our fiscal year. Code of Ethics and Anti-Bribery and Anti-Corruption (ABAC) training was launched in October 2024 across the globe and will be due in late December 2024, with completion metrics available in January 2025. The Code training is provided in 30 languages, and the ABAC training in 20 languages.
Looking ahead, we will continue to strengthen our global approach by driving consistency in our risk identification and tolerance, focusing on broader areas of compliance, continuing to centralize reporting function for all compliance officers, globalizing compliance policies, and enhancing role-based compliance training.
Elizabeth Campbell
EVP – Chief Legal Officer
